The Defense Logistics Agency (DLA) awarded a $8,232.42 firm fixed-price delivery order contract to Dakota Drug, Inc., a self-certified small disadvantaged business, for the provision of DUPIXENT 300 MG/2 ML SYRINGE 2ML. This order was placed under Dakota Drug's $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA, which supports the agency's ECAT Generation V Program for procuring commercial medical equipment, accessories, consumables, and simulation equipment. The contract has an ultimate completion date of August 2, 2024. Dakota Drug, Inc. has over 20 years of experience supplying critical pharmaceutical products and medical supplies to the U.S. Armed Forces through prime contracts and blanket purchase agreements with the DLA Troop Support Medical. This delivery order does not have a set-aside designation.
Generated 10/31/24, 10:14 AM